4 ms·

Too early to draw any conclusions

• 1letterunixname 3y ago
  Exactly. It's phase I testing. All they know is it doesn't seem to kill mice or some healthy cells in a Petri dish. Despite this being apparently a highly-targeted molecule, there is always the potential for it to cause side-effects, injuries, or fatalities in whole humans. It shows promise but wake me up when it passes phase III.